by Amy Berger | Sep 1, 2023 | Blog, News
At IITRI, we have a long history of direct contracts, subcontracts from commercial Sponsors, and supporting grants for numerous government agencies such as NCI, NIAID, NIH, CDC, BARDA, and DOD. We are also well positioned to support contracts with the newly...
by Amy Berger | Jul 18, 2023 | Blog, News
IITRI has the unique advantage of expertise with multiple non-human primate (NHP) animal models (cynos, african green monkeys, and marmosets) and comprehensive preclinical inhalation services for efficacy, safety, and toxicology programs. Our studies range from...
by Amy Berger | Jun 20, 2023 | Blog, Events, News
This weekend, members of our virology team will be attending the American Society for Virology’s Annual Meeting in Athens, Georgia. Albert will be presenting the poster “Contact Transmission Model of SARS-CoV-2 Delta Infection in Hamsters” during...
by Amy Berger | Mar 22, 2023 | Blog, News
The recent outbreaks of pan-resistant Candida auris and the alarming effects on health care facilities have brought to the forefront the challenges of combating drug-resistant pathogens. Since the typical treatment for Candida infections and most C. auris infections...
by Amy Berger | Dec 22, 2022 | Blog, News
IITRI is proud to share recent accomplishments from two of our technical divisions. Several members of our Microbiology and Molecular Biology Division authored a recent publication entitled “Characterization of Three Variants of SARS-CoV-2 In Vivo Shows...
by Amy Berger | Oct 26, 2022 | Blog, Events
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. They just announced the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with...
Recent Comments